Few recent drug launches have scaled as quickly as Rezdiffra, and the company behind it, Madrigal Pharmaceuticals, has become a case study in what a first-in-disease approval can do for a single-product biotech. Madrigal built its business around resmetirom, sold as Rezdiffra, the first therapy cleared by the FDA for…

The death of Abderrahim Fakir42 years old, occurred Sunday 19 July during a police intervention in the neighborhood Pillar of Bologna, is at the center of an investigation by the Prosecutor’s Office which will have to clarify the causes of death and verify the correctness of the procedures adopted during…

L’AI has established itself in the daily financial lives of the French more quickly than expected. In addition to help with tax declaration, according to the savings and investment barometer published by the AMF in June 2026, 11% of savers now consult an AI before making an investment, a share…